Close
Overlay

James Dzandu - Texas

James Dzandu
Send Message
Connect

About James Dzandu

James+Dzandu
James Dzandu is currently living in Texas, and is interested in Med. DevicesPharma.
Not the person you're looking for?
Find more results for James Dzandu

Location

Texas

Categories of Interest

Med. DevicesPharma

Resume

September 30, 2008
NAME: Dzandu, James K.
6925 Flint Cove Drive, Dallas, Texas 75248.
214-566-4603; E-mail: jkd2569@hotmail.com

CITIZENSHIP: U.S.A

OBJECTIVE: A Ph.D. Life Scientist seeking a position with top level pharmaceutical industry, prestigious medical research center, CRO or FDA to leverage academic, clinical research professional training, discovery research and experience to help achieve program goals.

SUMMARY:
Possess sound scientific knowledge, training in new drug discovery development and translational research project planning, implementation, monitoring and report writing.
Successfully completed 140 hrs CRA Certificate Program; thorough knowledge of GCP, ICH and FDA regulations.
Serve as IRB Chairman-Interim, review clinical trials for scientific merit and protection of human subjects (21 CFR 50; 21 CFR 56; 45 CFR 46); FDA/GCP and ICH/GCP.
Possess CLIA-certified, AABB-certified, CAP-approved clinical & Molecular Diagnostics/DNA Identity Laboratory Director experience; secured competitive grant funding in excess of $1,310,000.00 in 5 years; 35 scientific publications and abstracts.
Strong organizational skills, self-motivated, assertive, able to work independently or as part of a team; able to travel 40 to 50%.

EDUCATION/TRAINING

INSTITUTION LOCATION DEGREE or CERTIFICATE YEAR(s) FIELD
University of Ghana. Accra/Ghana B.S. 1967-1972 Chemistry & Biochemistry
Wayne State University, College of Medicine
Detroit Michigan, USA Ph.D. 1974-1980 Biochemistry Wayne State University. Detroit Michigan, USA Postdoctoral 1980-1982 Pathology & Physiology
University of North Texas Health Science Center, TX Postdoctoral 1982-1984 Anatomy and Cell Biology
Medical Research Management Training CRA certificate 2007-2008 Clinical Research Professional Training



APPOINTMENTS
2007- 2008 Interim Chairman & Consultant, Dallas Methodist Health System (6 months)
2006-2007 Senior Scientist, Department of Molecular and Cellular Biology University of Texas at Dallas
2002-2005 Director, Genetic Services, Sickle Cell Disease Association of America, Dallas.
1994-2002 Clinical Laboratory Director, Sickle Cell Laboratory, Fort Worth, Texas, CLIA ID # 45D0486179
1992-1997 Associate Director, DNA/Identity Laboratories, Department of Pathology, University of North Texas Health Science Center, Fort Worth, Texas.
1992-1997 Assistant Professor of Pathology, University of North Texas Health Science Center, Fort Worth, Texas.
1984-1992 Assistant Professor of Anatomy and Cell Biology, University of North Texas Health Science Center, Fort Worth, Texas.

AWARDS AND OTHER PROFESSIONAL ACTIVITIES
2006-Present Institutional Review Board, Dallas Methodist Hospital. Scientific member.
2006-Present Scientific Consultant IRB, Cooks Children Medical Center, Fort Worth, Texas
2005-2006 American Society for Advancement of Science-Member
1992-2006 Institutional Review Board, Cooks Children Medical Center, Fort Worth. Scientific member.
1997 National Institutes of Health (NIH) Invited Grant reviewer: Gene therapy for sickle cell disease
1992-1997 American Association of Blood Banks DNA Laboratory Accreditation Inspector
1995-1997 New York Academy of Sciences
1994-1997 National Medical Society, Associate Member
1995-1997 Electrophoresis Society
1974-1980 African-American Graduate Fellow/African-American Institute
1974-1980 US Agency for International Development Fellow (AID)

Publications
1. Dzandu, J.K., *Johnson, I. F. and Wise, G.E. Sodium Dodecyl Sulfate-Gel Electrophoresis: Staining of Polypeptides Using Heavy Metal Salts. Analytical. Biochem. 174, 157-167, 1988
2. *Deh, ME., Dzandu, J.K., and Wise, G.E., Sialoglycorproteins with High Amounts of 0- Glycosidically Linked Carbohydrate Moieties Stain Yellow with Silver in SDS-Polyacrylamide Gels. Analytical. Biochemistry. 150, 166-173, 1985
3. Dzandu, J.K., *Deh, M.E., and Wise, G.E., A Re-Examination of the Effects of Chymotrypsin, and Trypsin on the Erythrocyte Membrane Surface Topology. Biochem Biophys Res Commun. 16;126:50-58, 1985
4. Dzandu, J.K., *Deh M.E., and Keiner, P. Phosphorylation of Glycophorin A in membranes of Intact Human Erythrocytes. Biochem. Biophys. Res. Commun. 127: 878-884, 1985

5. Dzandu, J.K., *Deh, ME., Baratt, D. and Wise, G.E. Detection of Erythrocyte Membrane Proteins, Sialoglycoproteins and Lipids in a Single Polyacrylamide gel Using a Novel Double Staining Technique. Proceedings of the National Academy of Sciences, U.S.A. 81, 1733-1737, 1984
6. Dzandu, J.K., and Johnson R.M., Membrane Protein Phosphorylation in Intact Normal and Sickle Cell Erythrocytes, Journal of Biological Chemistry. 255, 6382-6386, 1980
7. Dzandu, J.K., Role of Sialic Acid in Selective Silver Staining of Red Cell Glycophorins: Journal of Applied and Theoretical Electrophoresis. 1, 137-144, 1989
8. Ding Wang, Dzandu, J.K., Hussain, N. and Johnson, R.M., Western Blots From SDS-PAGE Gels Stained by Metal Salts. Analytical Biochemistry 180, 311-313, 1989
9. Wise, G.E., Oakford, LX., and Dzandu, J.K., Ultra structure of a Transmembrane Glycoprotein, Glycophorin A., Tissue & Cell 20,219-227, 1988
10. Johnson, R. M., Dzandu, J.K, and Warth, A., The Phosphoproteins of the Sickle Cell Erythrocyte Membrane, Arch. Biochemica Biophysica Acta 244-202-210, 1986
11. Johnson, R.M., McGowan, M., Morse, P.M., and Dzandu, .J.K., Proteolytic Analysis of the Topological Arrangement of Red Cell Phosphoproteins, Biochemistry 21, 3599- 3604., 1982
12. Johnson, R.M., and Dzandu, J.K., Calcium and lonophore A23 187 Induce the Sickle Cell Membrane Phosphorylation Pattern in Normal Erythrocytes Biochemica. Biophysica. Acts 692, 218-222, 1982

Selected Abstracts
1. Xiao Yao, Dzandu, J.K., and Pace , B.S.: Characterization of Combinatorial Stat3/GATA-1 Complexes in the Gamma Globin 5UTR. 48th American Society of Hematology Annual Meeting Orlando FL December, 2006.
2. Dzandu, J.K., Collins, M.L., Scott, B.S., Morgan, D., and Freeman, R.: Analysis of Newborn Screening Follow-up Programs for Sickle Cell Trait: Challenge to Sickle Cell Stakeholders. 27th Annual Meeting of the National Sickle Cell Disease Program. Los Angeles. CA April 18-21, 2004.

Personal Statement: Possess through training and experience expertise to perform the role of Principal Investigator, Research team leader or Clinical Trial Manager in life science or clinical project management. Responsible for hypothesis-driven project designs, implementation and evaluation using GCP standards and SOPs to ensure subject safety, protocol adherence and production of valid study results for FDA IND and NDA submissions. Validate or re-formulate relevant standard operating procedures based on cross-cutting platforms; conduct discovery research; collect, analyze and report project data and present conclusions in meaningful fashion to stakeholders, including internal and external customers, regulatory agencies and professionals. Understand the development process for Drugs, Biologics, and Medical Devices. Maintain regulatory compliance with FDA submissions/approvals, ICH guidelines, GMP, GCP, CLIA, CAP and Quality Control and Quality Assurance Programs as they relate to primary areas of company enterprise. Effective verbal and written communication skills aimed at optimizing performance at varying levels of company organization, operation and analysis. Able to simultaneously handle multiple projects, prioritize work, supervise others and meet deadlines and pre-determined benchmarks. Anticipate project related expected and unexpected adverse events. Develop, implement and evaluate contingency plans to mitigate expected adverse events. Maintain cognitive and operational flexibility in functional areas to develop effective time-lined solutions to unexpected difficulties before they become obstacles to project progress.

Research Support
2005-2008 Health Resources and Services Administration, Child and Maternal Health (HRSA)
 Grant award: $555,000.00-Dr. Dzandu, Principal Investigator
2003-2005 Health Resources and Services Administration, Child and Maternal Health (HRSA)
 Grant award: $375,000.00-Dr. Dzandu, Principal Investigator
2002-2003 Health Resources and Services Administration, Child and Maternal Health (HRSA)
 Grant award: $185,000.00-Dr. Dzandu, Principal Investigator
2001-2002 Texas Department of Health Innovative Grant
 Grant award: $200,000.00-Dr. Dzandu, Principal Investigator
Grants Submitted: SAMSAH: $1,500,500.00

Skills: Theoretical understanding and hands-on expertise with basic life and clinical science research techniques to create new knowledge or find solutions to biological problems of interest. These skills, include proteomics, genomics, cell & molecular biology, biochemistry and immunology with special emphasis on discovery research. Additional pertinent analytical techniques aimed at finding biomarkers include, electrophoresis (1 & 2 dimensions), IEF, western & southern blotting; RFLP, multiplex-PCR, nucleic acid-based diagnostics, HPLC, spectroscopy, cell culture, transduction, electrophoretic mobility shift assays coupled with tandem protein mass spectroscopy (EMSA-MS/MS) and clinical laboratory testing. Research grant proposal development for funding by governments, private and commercial agencies with focus on biological research and health service programs.

CLINICAL RESEARCH PROFESSIONAL TRAINING (140 HOURS)
The drug research and development process, Identifying and reporting of non-serious and serious adverse events, principles of data management and query resolution, protocol development, case report form design, and informed consent writing.
Good clinical practices 21 CFR 312 IND, 21 CFR 50 Protection of Human Subjects, 21 CFR 56 IRB, 45 CFR 46, 21 CFR 54 Financial Disclosure by Clinical Investigators. International Conference on Harmonization (E6) GCP Consolidated Guideline and (E2A) Clinical Safety Data Management.
Monitoring method and responsibilities: Systematic approach to monitoring, managing essential documents and clinical trial materials. Selecting investigators and conducting pre-evaluation, study initiation, interim, and close out visits. Writing pre-visit letters, follow up letters, and site visit reports. Performed five mock site visits utilizing case studies and wrote example monitoring reports.
Criteria for Course Completion: Comprehensive course examination, ICH/GCP regulatory examination, and performing a site monitoring visit identifying 80% of the deficiencies

References available on request .

Quick Profile Summary

James Dzandu
Name: James Dzandu
Link: http://www.salespider.com/p-5906913/james-dzandu
Location: Texas,United States

Explore using SaleSpider

Businesses You May Be Interested In

 Business Picture
 Business Picture
 Business Picture
 Business Picture

People you may know from

 Business Picture
 Business Picture
 Business Picture
 Business Picture

James Dzandu’s Business Connections

Find more information on the Company

Share This Profile

Member Spotlight

Carl Davis Icon
Carl Davis
Their Missing
Private Investigations

Business Spotlight

Royal Crown Construction Icon
Royal Crown Construction
Http://www.royalcrownconstruction.ca/
»
»
»
James Dzandu
Who Viewed This Page
458376 views
Last Seen
Thursday August 11, 2016
Top Cities
Delhi 1.7%
Toronto 1.17%
Bangalore 1.1%
Top Browser
Chrome Chrome51.56%
Iphone16.42%
Firefox Firefox14.07%
OS Expand
Windows
42.06%
Android
27.51%
Iphone
16.91%
Device Expand
Desktop
50.37%
Mobile
43.63%
Tablet
5.99%
Language Expand
En-US
64.76%
En-us
17.89%
En-GB
2.84%
spacer pixel